The Project: Every Child Protocol: A Registry Eligibility Screening Biology and Outcome Study
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Childhood Relapsed Solid Tumor | Central Nervous System Neoplasm | Childhood Lymphoma
Age: Between 0 - 25 Years
Gender: Male or Female
In order to be eligible to take part in this trial, patients must meet the following criteria:
- Enrollment can occur at any time after disease presentation including at time of disease progression or recurrence; for patients who are to be enrolled on COG therapeutic studies, enrollment on APEC14B1 must occur prior to enrollment onto the therapeutic trial
- Subjects must be =< 25 years of age at time of original diagnosis, except for patients who are being screened specifically for eligibility onto a COG (or COG participating National Clinical Trials Network (NCTN) ) therapeutic study, for whom there is a higher upper age limit
For a full list of participation criteria, please visit clinicaltrials.gov.
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required